A Clinical Study of CHT101 in CD70-Positive Relapsed or Refractory Hematological Malignancies

Clinical trial NCT06914037 · RECRUITING

Trial details

NCT number: NCT06914037
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Peripheral T-cell Lymphoma Cutaneous T-cell Lymphoma (CTCL)NHL (Non-Hodgkin Lymphoma)

Start date: 2025-03-31
Primary completion: 2028-03-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.